Promore Pharma AB (publ)

Promore Pharma AB (publ)verified

PROMO.ST

Price:

$0.11

Market Cap:

$293.55M

Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which is in Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. It entered into a cooperation agreement with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. The company was formerly known as Lipopeptide AB and changed ...[Read more]

Industry

Biotechnology

IPO Date

2017-07-06

Stock Exchange

STO

Ticker

PROMO.ST

The ROE as of November 2025 (TTM) for Promore Pharma AB (publ) (PROMO.ST) is -97.51%

According to Promore Pharma AB (publ)’s latest financial reports and current stock price. The company's current ROE is -97.51%. This represents a change of -20.55% compared to the average of -122.73% of the last 4 quarters.

Promore Pharma AB (publ) (PROMO.ST) Historical ROE (quarterly & annually)

How has PROMO.ST ROE performed in the past?

The mean historical ROE of Promore Pharma AB (publ) over the last ten years is -96.97%. The current -97.51% ROE has changed 0.56% with respect to the historical average. Over the past ten years (40 quarters), PROMO.ST's ROE was at its highest in in the June 2017 quarter at 12.94%. The ROE was at its lowest in in the March 2017 quarter at -2137.86%.

Quarterly (TTM)
Annual

Average

-96.97%

Median

-82.05%

Minimum

-222.23%

Maximum

0%

Promore Pharma AB (publ) (PROMO.ST) ROE by Quarter and Year

Discovering the peaks and valleys of Promore Pharma AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 661.62%

Maximum Annual ROE = 0%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -222.23%

Quarterly (TTM)
Annual
YearROEChange
2022-190.30%186.61%
2021-66.40%-49.48%
2020-131.42%139.33%
2019-54.91%-43.80%
2018-97.70%661.62%
2017-12.83%-94.23%
2016-222.23%-Infinity%

Promore Pharma AB (publ) (PROMO.ST) Average ROE

How has PROMO.ST ROE performed in the past?

The current ROE of Promore Pharma AB (publ) (PROMO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-129.37%

5-year avg

-108.15%

10-year avg

-96.97%

Promore Pharma AB (publ) (PROMO.ST) ROE vs. Peers

How is PROMO.ST’s ROE compared to its peers?

Promore Pharma AB (publ)’s ROE is greater than Medivir AB (publ) (-37.65%), greater than ISR Immune System Regulation Holding AB (publ) (-211.70%), greater than Idogen AB (publ) (-652.21%), greater than Asarina Pharma AB (publ) (-157.86%), greater than Pharmiva AB (publ) (-82.12%), greater than Kancera AB (publ) (-70.36%), greater than Ziccum AB (publ) (-253.28%), greater than Cyxone AB (publ) (-53.52%), less than Medhelp Care Aktiebolag (publ) (21.13%), greater than Scandion Oncology A/S (-139.19%),

Build a custom stock screener for Promore Pharma AB (publ) (PROMO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Promore Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Promore Pharma AB (publ) (PROMO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Promore Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Promore Pharma AB (publ)'s ROE?

How is the ROE calculated for Promore Pharma AB (publ) (PROMO.ST)?

What is the highest ROE for Promore Pharma AB (publ) (PROMO.ST)?

What is the 3-year average ROE for Promore Pharma AB (publ) (PROMO.ST)?

What is the 5-year average ROE for Promore Pharma AB (publ) (PROMO.ST)?

How does the current ROE for Promore Pharma AB (publ) (PROMO.ST) compare to its historical average?